Polar Asset Management Partners Inc.
Position in RNA — Atrium Therapeutics, Inc.
CIK 1326389
TORONTO, A6
Position in RNA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$935,900
New position
Shares Held
70,000
first reported quarter
Ownership
0.409%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Polar Asset Management Partners Inc. holds $82,224,376 across 6 Biotechnology names. RNA ranks #6 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
|
725,000 | $38,222,000 | |
| 2 | FOLD |
AMICUS THERAPEUTICS, INC.
|
1,543,000 | $22,311,780 | |
| 3 | DAWN |
Day One Biopharmaceuticals, Inc.
|
630,410 | $13,515,990 | |
| 4 | TECH |
BIO-TECHNE Corp
|
98,100 | $5,126,706 | |
| 5 | OMER |
Omeros Corp
|
200,000 | $2,112,000 | |
| 6 | RNA |
Atrium Therapeutics, Inc.
This page
|
70,000 | $935,900 |
All Filings in RNA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $935,900 | 70,000 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||